natraliaeczema and psoriasis (LaCorium Health USA Inc.)


Welcome to the PulseAid listing for the natralia drug offered from LaCorium Health USA Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: LaCorium Health USA Inc.
NON-PROPRIETARY NAME: Sodium Borate, Graphite, Potassium Sulfate, and Sodium Chloride
SUBSTANCE NAME: SODIUM BORATE; GRAPHITE; POTASSIUM SULFATE; SODIUM CHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2009-03-01
END MARKETING DATE: 0000-00-00


natralia eczema and psoriasis HUMAN OTC DRUG Details:

Item Descriptionnatralia eczema and psoriasis from LaCorium Health USA Inc.
LABELER NAME: LaCorium Health USA Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20; 6; 3; 12([hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g)
START MARKETING DATE: 2009-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43251-2241_24cc1f5a-9cdc-4dd3-bf59-33acd9cb6362
PRODUCT NDC: 43251-2241
APPLICATION NUMBER:

Other SODIUM BORATE; GRAPHITE; POTASSIUM SULFATE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
LaCorium Health International Pty LtdFlexitol Naturals Eczema and Psoriasis
LaCorium Health USA Inc.natralia